AK Medical Holdings Limited Logo

AK Medical Holdings Limited

1789.HK

(2.2)
Stock Price

5,24 HKD

7.47% ROA

8.63% ROE

25.18x PER

Market Cap.

5.150.883.454,58 HKD

3.52% DER

0.98% Yield

17.13% NPM

AK Medical Holdings Limited Stock Analysis

AK Medical Holdings Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

AK Medical Holdings Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (2%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Assets Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

3 Dividend

Investors can trust the company's impressive dividend track record, consistently distributing dividends over the past five years, showcasing a strong commitment to rewarding shareholders.

4 ROE

ROE in an average range (9.58%) suggests satisfactory profitability and decent utilization of shareholders' equity.

5 ROA

The stock's ROA (8.17%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

6 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (40), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

7 PBV

The stock's high Price-to-Book Value (P/BV) ratio (3.29x) suggests it's overvalued, potentially making it an expensive investment.

8 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

10 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

11 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

AK Medical Holdings Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

AK Medical Holdings Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

AK Medical Holdings Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

AK Medical Holdings Limited Revenue
Year Revenue Growth
2014 148.278.000
2015 206.164.000 28.08%
2016 270.777.000 23.86%
2017 372.700.000 27.35%
2018 600.562.000 37.94%
2019 926.705.000 35.19%
2019 926.705.000 0%
2020 1.035.386.000 10.5%
2021 761.441.000 -35.98%
2022 1.052.047.000 27.62%
2023 1.093.862.000 3.82%
2024 2.848.205.572 61.59%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

AK Medical Holdings Limited Research and Development Expenses
Year Research and Development Expenses Growth
2014 15.539.000
2015 18.878.000 17.69%
2016 20.390.000 7.42%
2017 34.963.000 41.68%
2018 45.595.000 23.32%
2019 80.527.000 43.38%
2019 80.527.000 0%
2020 104.974.000 23.29%
2021 113.069.000 7.16%
2022 110.865.000 -1.99%
2023 137.126.000 19.15%
2024 275.565.540 50.24%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

AK Medical Holdings Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2014 19.277.000
2015 32.030.000 39.82%
2016 50.291.000 36.31%
2017 56.222.000 10.55%
2018 74.125.000 24.15%
2019 92.203.000 19.61%
2019 92.203.000 0%
2020 83.016.000 -11.07%
2021 105.316.000 21.17%
2022 118.313.000 10.99%
2023 133.441.000 11.34%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

AK Medical Holdings Limited EBITDA
Year EBITDA Growth
2014 62.314.000
2015 78.047.000 20.16%
2016 102.142.000 23.59%
2017 137.129.000 25.51%
2018 191.967.000 28.57%
2019 354.223.000 45.81%
2019 341.380.000 -3.76%
2020 438.411.000 22.13%
2021 184.326.000 -137.85%
2022 322.865.000 42.91%
2023 323.343.000 0.15%
2024 648.397.156 50.13%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

AK Medical Holdings Limited Gross Profit
Year Gross Profit Growth
2014 101.345.000
2015 142.056.000 28.66%
2016 187.311.000 24.16%
2017 263.790.000 28.99%
2018 408.881.000 35.48%
2019 643.251.000 36.44%
2019 643.251.000 0%
2020 714.532.000 9.98%
2021 499.189.000 -43.14%
2022 636.435.000 21.56%
2023 674.486.000 5.64%
2024 1.727.209.712 60.95%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

AK Medical Holdings Limited Net Profit
Year Net Profit Growth
2014 51.721.000
2015 64.907.000 20.32%
2016 77.326.000 16.06%
2017 105.376.000 26.62%
2018 144.936.000 27.29%
2019 266.992.000 45.72%
2019 266.992.000 0%
2020 314.007.000 14.97%
2021 92.619.000 -239.03%
2022 204.772.000 54.77%
2023 182.104.000 -12.45%
2024 603.591.480 69.83%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

AK Medical Holdings Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

AK Medical Holdings Limited Free Cashflow
Year Free Cashflow Growth
2014 43.661.000
2015 7.630.000 -472.23%
2016 39.795.000 80.83%
2017 64.603.000 38.4%
2018 54.463.000 -18.62%
2019 37.744.000 -44.3%
2019 9.436.000 -300%
2020 115.470.000 91.83%
2021 100.392.000 -15.02%
2022 121.202.000 17.17%
2023 -51.123.000 337.08%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

AK Medical Holdings Limited Operating Cashflow
Year Operating Cashflow Growth
2014 51.092.000
2015 36.302.000 -40.74%
2016 69.643.000 47.87%
2017 116.652.000 40.3%
2018 127.992.000 8.86%
2019 144.662.000 11.52%
2019 36.165.500 -300%
2020 205.257.000 82.38%
2021 176.621.000 -16.21%
2022 242.919.000 27.29%
2023 19.577.000 -1140.84%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

AK Medical Holdings Limited Capital Expenditure
Year Capital Expenditure Growth
2014 7.431.000
2015 28.672.000 74.08%
2016 29.848.000 3.94%
2017 52.049.000 42.65%
2018 73.529.000 29.21%
2019 106.918.000 31.23%
2019 26.729.500 -300%
2020 89.787.000 70.23%
2021 76.229.000 -17.79%
2022 121.717.000 37.37%
2023 70.700.000 -72.16%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

AK Medical Holdings Limited Equity
Year Equity Growth
2014 155.951.000
2015 176.938.000 11.86%
2016 294.393.000 39.9%
2017 667.983.000 55.93%
2018 841.758.000 20.64%
2019 1.116.010.000 24.57%
2020 2.042.776.000 45.37%
2021 2.031.551.000 -0.55%
2022 2.243.761.000 9.46%
2023 2.391.903.000 6.19%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

AK Medical Holdings Limited Assets
Year Assets Growth
2014 212.647.000
2015 283.750.000 25.06%
2016 405.535.000 30.03%
2017 857.607.000 52.71%
2018 1.092.800.000 21.52%
2019 1.482.226.000 26.27%
2020 2.526.906.000 41.34%
2021 2.605.284.000 3.01%
2022 2.774.492.000 6.1%
2023 3.003.024.000 7.61%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

AK Medical Holdings Limited Liabilities
Year Liabilities Growth
2014 56.696.000
2015 106.812.000 46.92%
2016 111.142.000 3.9%
2017 189.624.000 41.39%
2018 251.042.000 24.47%
2019 366.216.000 31.45%
2020 484.130.000 24.36%
2021 573.733.000 15.62%
2022 530.731.000 -8.1%
2023 611.121.000 13.15%

AK Medical Holdings Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.07
Net Income per Share
0.18
Price to Earning Ratio
25.18x
Price To Sales Ratio
4.32x
POCF Ratio
151.69
PFCF Ratio
-34.37
Price to Book Ratio
2.15
EV to Sales
4.11
EV Over EBITDA
18.98
EV to Operating CashFlow
144.51
EV to FreeCashFlow
-32.72
Earnings Yield
0.04
FreeCashFlow Yield
-0.03
Market Cap
5,15 Bil.
Enterprise Value
4,90 Bil.
Graham Number
2.97
Graham NetNet
0.73

Income Statement Metrics

Net Income per Share
0.18
Income Quality
0.19
ROE
0.09
Return On Assets
0.07
Return On Capital Employed
0.08
Net Income per EBT
0.8
EBT Per Ebit
1.23
Ebit per Revenue
0.17
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
0.05
Research & Developement to Revenue
0.12
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.6
Operating Profit Margin
0.17
Pretax Profit Margin
0.21
Net Profit Margin
0.17

Dividends

Dividend Yield
0.01
Dividend Yield %
0.98
Payout Ratio
0.3
Dividend Per Share
0.05

Operating Metrics

Operating Cashflow per Share
0.03
Free CashFlow per Share
-0.13
Capex to Operating CashFlow
5.42
Capex to Revenue
0.15
Capex to Depreciation
2.07
Return on Invested Capital
0.07
Return on Tangible Assets
0.07
Days Sales Outstanding
162.21
Days Payables Outstanding
132.48
Days of Inventory on Hand
451.02
Receivables Turnover
2.25
Payables Turnover
2.76
Inventory Turnover
0.81
Capex per Share
0.16

Balance Sheet

Cash per Share
0,65
Book Value per Share
2,14
Tangible Book Value per Share
1.9
Shareholders Equity per Share
2.14
Interest Debt per Share
0.08
Debt to Equity
0.04
Debt to Assets
0.03
Net Debt to EBITDA
-0.96
Current Ratio
3.96
Tangible Asset Value
2,12 Bil.
Net Current Asset Value
1,36 Bil.
Invested Capital
2252990000
Working Capital
1,48 Bil.
Intangibles to Total Assets
0.09
Average Receivables
0,61 Bil.
Average Payables
0,23 Bil.
Average Inventory
567183000
Debt to Market Cap
0.02

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

AK Medical Holdings Limited Dividends
Year Dividends Growth
2018 0
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

AK Medical Holdings Limited Profile

About AK Medical Holdings Limited

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spine replacement implants; and 3D-printed products, such as 3D-printed hip replacement implants, 3D-printed artificial vertebral bodies, and 3D-printed spinal interbody cages. The company also distributes third party orthopedic products; and manufactures surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. AK Medical Holdings Limited is a subsidiary of Ximalaya Limited.

CEO
Mr. Zhijiang Li
Employee
974
Address
Xingye Building
Beijing, 102200

AK Medical Holdings Limited Executives & BODs

AK Medical Holdings Limited Executives & BODs
# Name Age
1 Ms. Rongkun Ma
Company Secretary
70
2 Mr. Hanzhong Sun
Vice President of Human Resources
70
3 Mr. Zhijiang Li
Chairman & Chief Executive Officer
70
4 Ms. Bin Mo Zhang
Senior Vice President & Executive Director
70
5 Mr. Chaoyang Zhang
Senior Vice President & Executive Director
70
6 Ms. Xiaohong Zhao
Executive Director
70
7 Ms. Kun Liang
Chief Financial Officer
70

AK Medical Holdings Limited Competitors